Ángel Rodríguez-Villodres

ORCID: 0000-0001-6373-9724
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Antibiotic Resistance in Bacteria
  • Antibiotics Pharmacokinetics and Efficacy
  • Antibiotic Use and Resistance
  • Pneumonia and Respiratory Infections
  • Bacterial Identification and Susceptibility Testing
  • Urinary Tract Infections Management
  • COVID-19 Clinical Research Studies
  • Salmonella and Campylobacter epidemiology
  • Clostridium difficile and Clostridium perfringens research
  • Listeria monocytogenes in Food Safety
  • SARS-CoV-2 and COVID-19 Research
  • Vibrio bacteria research studies
  • Escherichia coli research studies
  • Antimicrobial Resistance in Staphylococcus
  • Patient Satisfaction in Healthcare
  • Gut microbiota and health
  • Infections and bacterial resistance
  • Long-Term Effects of COVID-19
  • Nosocomial Infections in ICU
  • Mycobacterium research and diagnosis
  • Essential Oils and Antimicrobial Activity
  • Pharmaceutical and Antibiotic Environmental Impacts
  • Bacterial biofilms and quorum sensing
  • Amoebic Infections and Treatments
  • Medicinal Plants and Neuroprotection

Universidad de Sevilla
2017-2025

Hospital Universitario Virgen del Rocío
2015-2025

Centro de Investigación Biomédica en Red
2023-2025

Instituto de Biomedicina de Sevilla
2017-2024

Instituto de Salud Carlos III
2023-2024

Health Research Institute of the Balearic Islands
2023

University of Fribourg
2019

Miquel Àngel Sastre-Femenía Almudena Fernández-Muñoz María A. Gomis-Font Biel Taltavull Carla López-Causapé and 95 more Jorge Arca-Suárez Luis Martínez‐Martínez Rafael Cantón Nieves Larrosa Jesús Oteo Laura Zamorano Antonio Oliver Fátima Galán‐Sánchez Irene Gracia-Ahufinger Luis Martínez‐Martínez Carmen Liébana-Martos Carolina Roldán Juan Manuel Sánchez‐Calvo Encarnación Clavijo Laura Mora-Navas Javier Aznar José Antonio Lepe Ángel Rodríguez-Villodres Esther Recacha Francisco Javier Casas-Círia Carmen Martínez-Rubio M Sempere Lina Martín-Hita Cristina Seral Ana Isabel López‐Calleja Carmen Aspíroz Marisa Monforte Pedro de la Iglesia-Martínez Gemma Jiménez-Guerra Elena Riera-Pérez María Carmen Collado Carmen Gallegos Xavier Mulet Almudena Fernández-Muñoz Miquel Àngel Sastre-Femenía María A. Gomis-Font Laura Zamorano Antonio Oliver María Siller‐Ruiz Jorge Calvo Dolores Eliche‐Quesada Jun Hao Wang Cristina Pitart Francesc Marco Núria Prim Juan Pablo Horcajada Eduardo Padilla Ester del Barrio-Tofiño Belen Viñado-Pérez Nieves Larrosa Fé Tubau Sílvia Capilla Antonio Casabella Mar Olga Pérez-Moreno Emma Padilla Mónica Ballestero Alba Rivera Ferrán Navarro Frederic Gómez Sergio Pardo-Granell Ester Picó-Plana Dolores Guerrero Carolina Sarvisé-Buil Alba Bellés Bellés Marta Fernández-Esgueva María del Pilar Ortega-Lafont Inmaculada García Noelia Arenal-Andrés Susana Hernando-Real Rosario Ibáñez Jesús Martı́nez Federico Becerra-Aparicio Carmen Aldea-Mansilla Asmaa Alaoui-Sosse José Carlos González Julia Guzmán-Puche Miguel Ángel Blázquez-Andrada Nora Mariela Martínez-Ramírez Alicia Beteta Bárbara Gomila-Sard Salvador Giner Almaraz Eugenio Garduño Pedro Miguel Juiz-González Jorge Arca-Suárez J. Corpas Alba P. Alonso Alonso Ana Isabel Rodríguez María Isabel Paz-Vidal Marta García‐Campello Pablo Camacho María de los Ángeles Pallarés María de Toro Amparo Coira Gema Barbeito Anniris Rincón

Pseudomonas aeruginosa healthcare-associated infections are one of the top antimicrobial resistance threats world-wide. In order to analyze current trends, we performed a Spanish nation-wide high-resolution analysis susceptibility profiles, genomic epidemiology and resistome P. over five-year time lapse.A total 3.180 nonduplicated clinical isolates from two surveys in October 2017 2022 were analyzed. MICs 13 antipseudomonals determined by ISO-EUCAST. Multidrug (MDR)/extensively drug...

10.1016/j.lanepe.2023.100736 article EN cc-by-nc-nd The Lancet Regional Health - Europe 2023-09-19
Belén Gutiérrez‐Gutiérrez María Dolores del Toro Alberto M. Borobia Antonio J. Carcas Inmaculada Jarrín and 95 more María Yllescas Pablo Ryan Jerónimo Pachón Jordi Carratalá Juan Berenguer José Ramón Arribas Jesús Rodríguez‐Baño Esther Aznar Muñoz Pedro Gil Divasson Patricia González Muñiz Clara Aguirre Pilar Retamar Adoración Valiente Luis Eduardo López-Cortés Jesús Sojo-Dorado José María Bravo-Ferrer Elena Salamanca Zaira R. Palacios‐Baena Patricia Pérez‐Palacios M. Gandullo-Moro Rocío Ruíz-Hueso Natalia Moya-González Agustín Valido-Morales María Pavón-Masa Marta Díaz‐Menéndez Fernando Calle Marta Arsuaga Vicente Elena Trigo Esteban Rosa de Miguel Buckley Julen Cadiñanos Carmen Busca Rafael Micán Marta Mora-Rillo Belén Loeches Yagüe José I. Bernardino Julio García‐Rodríguez Rocío Montejano Beatriz Díaz‐Pollán Juan Carlos López Margarita Ramírez-Schacke Isabel Gutiérrez Francisco Tejerina Teresa Aldámiz‐Echevarría Cristina Díez Chiara Fanciulli Leire Pérez‐Latorre F Parras Pilar Catalán María E. García-Leoni Isabel Pérez-Tamayo Luís Puente‐Maestu Jamil Cedeño A. Such-Díaz Elena Alba Álvaro-Alonso Elsa Izquierdo-García Juan Torres‐Macho Guillermo Cuevas Helena Notario B. Mestre-Gómez Eva Jiménez Inés Fernández-Jiménez Ana Josefa Tebar-Martínez Fátima Brañas Jorge Valencia Mario Pérez Marta Alvarado Gabriela Abelenda-Alonso Carmen Ardanuy Alba Bergas Guillermo Cuervo M.Á. Domínguez Miguel Fernández-Huerta Carlota Gudiol Laia Lorenzo-Esteller Jordí Niubó Sandra Pérez‐Recio Daniel Podzamczer Miquel Pujol Alexander Rombauts Núria Trullen José Miguel Cisneros Cristina Amodeo Pedro Camacho Núria Espinosa Manuel García‐Gutiérrez Luis Jara‐Palomares Rocío González-León José Molina Maria Martin María Paniagua Manuel Poyato Borrego Ángel Rodríguez-Villodres Zaida Ruiz de Azua Celia Salamanca Mo Antonia Sepúlveda Berrocal

10.1016/s1473-3099(21)00019-0 article EN other-oa The Lancet Infectious Diseases 2021-02-24

Due to the emergence of antimicrobial resistance, new alternative therapies are needed. Silver was used treat bacterial infections since antiquity due its known properties. Here, we aimed evaluate in vitro activity colloidal silver (CS) against multidrug-resistant (MDR) Gram-negative and Gram-positive bacteria. A total 270 strains (Acinetobacter baumannii (n = 45), Pseudomonas aeruginosa 25), Escherichia coli 79), Klebsiella pneumoniae 58)], Staphylococcus aureus 34), epidermidis 14),...

10.3390/antibiotics9010036 article EN cc-by Antibiotics 2020-01-19

The ESCPM group (Enterobacter species including Klebsiella aerogenes - formerly Enterobacter aerogenes, Serratia species, Citrobacter freundii complex, Providencia and Morganella morganii) has not yet been incorporated into systematic surveillance programs. We conducted a multicentre retrospective observational study analysing all strains isolated from blood cultures in 27 European hospitals over 3-year period (2020-2022). Diagnostic approach, epidemiology, antimicrobial susceptibility were...

10.1016/j.ijantimicag.2024.107115 article EN cc-by International Journal of Antimicrobial Agents 2024-02-16
Mariana G. López Álvaro Chiner‐Oms Darı́o Garcı́a de Viedma Paula Ruiz-Rodríguez María Alma Bracho and 95 more Irving Cancino‐Muñoz Giuseppe D’Auria Griselda De Marco Neris García‐González Galo A. Goig Inmaculada Gómez-Navarro Santiago Jiménez Llúcia Martínez‐Priego Paula Ruiz-Hueso Lidia Ruiz-Roldán Manuela Torres‐Puente Juan Alberola Eliseo Albert Maitane Aranzamendi María Pilar Bea-Escudero José Antonio Boga Antoni E. Bordoy Andrés Canut-Blasco Ana Carvajal Gustavo Cilla Eguiluz Maria Luz Cordón Rodríguez José Javier Costa-Alcalde María de Toro Inmaculada de Toro-Peinado José Luís del Pozo Sebastián Duchêne Jovita Fernández‐Pinero Begoña Fuster Escrivá Concepción Gimeno Cardona Verónica González Galán Nieves Gonzalo Jiménez Silvia Hernáez Crespo Marta Herránz José Antonio Lepe Carla López-Causapé José Luís López-Hontangas Vicente Martín Elisa Martró Ana Milagro Milagrosa Montes Ros Rosario Moreno-Muñoz David Navarro José María Navarro‐Marí Anna Not Antonio Oliver Begoña Palop-Borrás Mónica Parra Grande Irene Pedrosa-Corral Maria Carmen Pérez González Laura Pérez-Lago Mercedes Pérez-Ruiz Luis Piñeiro Vázquez Núria Rabella Antonio Rezusta Lorena Robles Fonseca Ángel Rodríguez-Villodres Sara Sanbonmatsu‐Gámez Jon Sicilia Álex Soriano María Dolores Tirado Balaguer Ignacio Torres Alexander Tristancho-Baró José María Marimón Manuela Torres‐Puente Jordi Pèrez‐Tur Darı́o Garcı́a de Viedma Pilar Catalán-Alonso Julia Suárez González Patricia Muñóz Paula Ruiz-Rodríguez María Alma Bracho Llúcia Martínez‐Priego Inmaculada Galán-Vendrell Griselda De Marco María Loreto Ferrús-Abad Sandra Carbó-Ramírez José Miguel Nogueira Juan J. Camarena David Navarro Óscar Martínez Expósito Nerea Antona Urieta María de Toro Cristian Castelló-Abiétar Susana Rojo‐Alba Marta Elena Álvarez‐Argüelles Santiago Melón Adrián Antuori Anabel Fernández María Concepción Lecaroz Agara Carmen Gómez-González Amaia Aguirre-Quiñonero José Israel López-Mirones Marina Fernández-Torres Maria Rosario Almela-Ferrer Juan Miguel Fregeneda-Grandes

10.1038/s41588-021-00936-6 article EN other-oa Nature Genetics 2021-09-30

Human infections by Bordetella bronchiseptica are increasing in recent years. However, due to the lack of clinical susceptibility/resistance breakpoints, antimicrobial treatment is complex. Business Intelligence (BI) a tool that allows record and analyze large amounts data very short time. The aim this study was cohort patients with B. focusing on how BI can help guide empirical therapy Demographic, clinical, microbiological about were recovered. Then, MIC50/90 several antibiotics...

10.37201/req/125.2024 article EN cc-by-nc Revista Española de Quimioterapia 2025-03-13

Background/Objectives: Meropenem (MER) is widely used for the treatment of Pseudomonas aeruginosa infections; however, increasing resistance compromises its efficacy. This study aimed to develop a selective culture medium detection meropenem-resistant P. from respiratory specimens within 24 hours. Methods: The performance was challenged using collection 130 clinical strains (85 MER-susceptible, 14 MER-intermediate, and 21 MER-resistant). Subsequently, validation carried out samples. Results:...

10.20944/preprints202503.1367.v1 preprint EN 2025-03-18
Sonsoles Salto‐Alejandre Judith Berastegui‐Cabrera Pedro Camacho‐Martínez Carmen Infante-Domínguez Marta Carretero-Ledesma and 94 more Juan Carlos Crespo‐Rivas Eduardo Márquez Martín José Manuel Lomas Claudio Bueno Rosario Amaya José Antonio Lepe José Miguel Cisneros Jerónimo Pachón Elisa Cordero Javier Sánchez‐Céspedes José Miguel Cisneros Manuela Aguilar‐Guisado Almudena Aguilera Clara Aguilera T. Aldabó-Pallás Verónica Alfaro‐Lara Cristina Amodeo Javier Ampuero María Dolores Avilés Maribel Asensio Bosco Barón‐Franco L. Barrera Pulido Rafael Bellido-Alba Máximo Bernabéu-Wittel Candela Caballero‐Eraso Macarena Cabrera‐Serrano Enrique J. Calderón J. Carbajal-Guerrero Manuela Cid-Cumplido Y. Corcia-Palomo Juan Delgado Antonio Domínguez-Petit Alejandro Deniz Reginal Dusseck-Brutus Ana Escoresca‐Ortega Núria Espinosa Núria Espinosa Michelle Espinoza Carmen Ferrándiz‐Millón Marta Ferrer‐García Teresa Ferrer Ignacio Gallego-Texeira Rosa Gámez-Mancera Emilio Gutiérrez Horacio García-Delgado Manuel García‐Gutiérrez María Luisa Gascón-Castillo Aurora González-Estrada Demetrio González Carmen Gómez-González Rocío González-León Carmen Grande-Cabrerizo Sonia Celedonia Huyhua Gutiérrez Carlos Hernández-Quiles Inmaculada Concepción Herrera-Melero Marta Herrero Luis Jara‐Palomares Carlos Jiménez-Juan Silvia Jiménez‐Jorge Mercedes Jiménez-Sánchez Julia Lanseros-Tenllado Carmina López Isabel López Álvaro López-Barrios Luís F. López‐Cortés Rafael Luque‐Márquez Daniel Macías‐García Guillermo Martín-Gutiérrez Luis Martín-Villén José Molina Aurora Fernández‐Cañadas Morillo María Dolores Navarro-Amuedo Dolores Nieto-Martín Francisco Órtega Ruiz María Paniagua‐García Amelia Peña-Rodríguez Esther Pérez‐Herrán Manuel Poyato Borrego Julia Praena‐Segovia Rafaela Ríos Cristina Roca-Oporto Jesús Flores Rodríguez María Jesús Rodríguez-Hernández Santiago Rodríguez-Suárez Ángel Rodríguez-Villodres Nieves Romero-Rodríguez Ricardo Ruiz Zaida Ruiz de Azua Celia Salamanca Sonia Sánchez Víctor Manuel Sánchez-Montagut César Sotomayor A. Suarez Javier Toral

Abstract The aim was to assess the ability of nasopharyngeal SARS-CoV-2 viral load at first patient’s hospital evaluation predict unfavorable outcomes. We conducted a prospective cohort study including 321 adult patients with confirmed COVID-19 through RT-PCR in swabs. Quantitative Synthetic RNA cycle threshold values were used calculate log 10 copies/mL. Disease severity end follow up categorized into mild, moderate, and severe. Primary endpoint composite intensive care unit (ICU) admission...

10.1038/s41598-021-92400-y article EN cc-by Scientific Reports 2021-06-21

Abstract Objectives Escherichia coli is characterized by three resistance patterns to β-lactams/β-lactamase inhibitors (BLs/BLIs): (i) ampicillin/sulbactam and susceptibility amoxicillin/clavulanic acid piperacillin/tazobactam (RSS); (ii) acid, (RRS); (iii) ampicillin/sulbactam, (RRR). These are acquired consecutively, indicating a potential risk of developing piperacillin/tazobactam, but the precise mechanism this process not completely understood. Methods Clinical isolates incrementally...

10.1093/jac/dkz393 article EN Journal of Antimicrobial Chemotherapy 2019-08-20

Piperacillin-tazobactam resistance (P/T-R) is increasingly reported among Escherichia coli isolates. Although in vitro experiments have suggested that blaTEM gene plays a key role the P/T-R acquisition, no clinical vivo study has yet confirmed of or other genes. Therefore, we aimed to identify mechanisms underlying by following up patients with E. complicated intra-abdominal infections (cIAI) who experienced P/T treatment failure. Four pairs strains, clonally related from four patients, were...

10.1016/j.jinf.2023.07.005 article EN cc-by Journal of Infection 2023-07-11
Germán Peñalva Juan Carlos Crespo‐Rivas Ana Belén Guisado-Gil Ángel Rodríguez-Villodres María Eugenia Pachón-Ibáñez and 76 more Bárbara Cachero-Alba Blas Rivas-Romero Josefa Gil-Moreno María Isabel Galvá-Borras Mercedes García-Moreno María Dolores Salamanca-Bautista Manuel Bautista Martínez-Rascón María Rosa Cantudo-Cuenca Ruth Concepción Ninahuaman-Poma María de los Ángeles Enrique-Mirón Aurora Pérez-Barroso Inmaculada Marín-Ariza Miguel González-Florido María del Rosario Mora-Santiago S Belda-Rustarazo José Antonio Expósito-Tirado Clara Rosso-Fernández María Victoria Gil-Navarro José Antonio Lepe José Miguel Cisneros Francisco Pérez Virginia Martínez-Ortega Begoña Palop-Borrás Jesús María Fernández-Martín Francisco Pradas de la Fuente Pedro Suárez-Uceda Antonio Andrés Quesada-Sanz M. López-López María Teresa Ruiz-Rico Javier Sánchez José María Jiménez-Páez María Rocío Luque-Montilla Lucrecia García-Martinez Pilar Egea-Miranda Francisco José Aguilera Carmen Amores-Antequera José Manuel Fernández-Suárez Virginia Gutiérrez-Rojas Antonio Francisco Guzmán-González Raquel Sánchez-Moral Manuel Cámara-Mestres María Carmen Domínguez-Jiménez Dulcenombre María García-Delgado José Piedrabuena-Molina María Dolores López-Prieto V Vazquez-Vela Juan Bautista Lázaro María Carmen Cruz-Díaz R. Robles de Medina Ana Isabel Aller-García Ana Sánchez Julio Cañizares Laura Lahera R. Ramos-Moreno Carmen M. Puche G. J. Villares O. Sanchez Hurtado Fernando Fernández Sánchez Cristina Sánchez-Martı́nez Josefa Caballero María González-López Manuel Rodríguez-Maresca Susana Cifuentes-Cabello Waldo Eugenio Sánchez-Yebra María Carmen Ruiz-Antón Mónica Figueroa-Molina José Bernardo Molina-Cabello Francisco Ferrer-Amate Inés Ruiz-Molina Francisca Vilches Yolanda Santaella-Guardiola José Ramón Ávila-Álvarez Myriam Gallego-Galisteo Gema Labrador-Herrera Laura Herrera‐Hidalgo Silvia Jiménez‐Jorge

Abstract Background Antimicrobial stewardship programs (ASPs) are recommended in nursing homes (NHs), although data limited. We aimed to determine the clinical and ecological impact of an ASP for NHs. Methods performed a cluster, randomized, controlled trial before–after study with interrupted time-series analyses 14 NHs 30 consecutive months from July 2018 December 2020 Andalusia, Spain. Seven facilities implemented bundle 5 educational measures (general ASP) 7 added 1-to-1 interviews...

10.1093/cid/ciac834 article EN cc-by-nc-nd Clinical Infectious Diseases 2022-10-21

Abstract Objectives To analyse the susceptibility profile to cefepime, carbapenems and new β-lactam/β-lactamase inhibitor combinations in Enterobacter cloacae complex Klebsiella aerogenes isolated from intra-abdominal, urinary, respiratory bloodstream infections SMART (Study for Monitoring Antimicrobial Resistance Trends) surveillance study Spain. Methods The susceptibilities of 759 isolates (473 E. 286 K. aerogenes) collected 11 Spanish hospitals 2016 2022 were analysed following EUCAST...

10.1093/jacamr/dlae087 article EN cc-by JAC-Antimicrobial Resistance 2024-05-06

Piperacillin/tazobactam (TZP) is a β-lactam/β-lactamase inhibitor (BL/BLI) recommended for the empirical treatment of severe infections. The excessive and indiscriminate use TZP has promoted emergence TZP-resistant Escherichia coli isolates. Recently, we demonstrated that may contribute to development

10.1128/spectrum.00801-21 article EN cc-by Microbiology Spectrum 2021-10-25

Seven CTX-M-27-producing Shigella sonnei strains were isolated at the University Hospital Virgen del Rocío (Seville, Spain) microbiology service from October to November 2021.To offer extensive information on microbiological and molecular epidemiology results of seven S. isolates compare them with other previously documented associated MSM transmission.S. stool samples patients acute diarrhoea identified through biochemical serological typing. Whole characterization was performed by...

10.1093/jacamr/dlac090 article EN JAC-Antimicrobial Resistance 2022-09-05

The objective of this study was to evaluate the accuracy MDR Direct Flow Chip Kit for detection antimicrobial resistance (AMR) determinants from bacterial colonies. Ninety-two clinical isolates with known AMR genotypically characterized were used. is a microarray-based assay that included 55 beta-lactams (23), quinolones (13), aminoglycosides (5), macrolides sulfonamides (3), colistin (2), vancomycin chloramphenicol (1), and linezolid (1). correctly detects 52 53 tested. cfr gene (linezolid...

10.1089/mdr.2022.0264 article EN Microbial Drug Resistance 2023-03-24

Abstract Piperacillin-tazobactam resistance (P/T-R) is increasingly reported among Escherichia coli isolates. Although in vitro experiments have suggested that blaTEM gene plays a key role the P/T-R acquisition, no clinical vivo study has yet confirmed of or other genes. Therefore, we aimed to identify mechanisms underlying by following up patients with E. intraabdominal infections (IAI) who experienced P/T treatment failure. We found higher copy number isolates, generated three different...

10.21203/rs.3.rs-2752509/v1 preprint EN cc-by Research Square (Research Square) 2023-03-30

To evaluate the clinical and epidemiological impact of a new molecular surveillance strategy based on qPCR to control an outbreak by Serratia marcescens in Neonatal Intensive Care Unit (NICU).We design specific for detection S. rectal swabs patients admitted NICU. We divided study into two periods: (a) pre-PCR, from declaration introduction, (b) PCR period, introduction until was solved. In all cases, isolates were recovered their clonal relationship analysed PFGE. Control measures...

10.1186/s12941-023-00657-0 article EN cc-by Annals of Clinical Microbiology and Antimicrobials 2023-12-11

Escherichia coli is the most frequent Gram-negative bacilli involved in intra-abdominal infections. However, despite high mortality rates associated with biliary tract infections due to E. coli, there no study focusing on this pathogen. In study, we have characterized a group of 15 isolates obtained from 12 patients Demographic and clinical data were recovered. Phylogeny, resistome, virulome analysis through whole genome sequencing biofilm formation investigated. Among isolates, predominant...

10.3390/jcm8122118 article EN Journal of Clinical Medicine 2019-12-02
Coming Soon ...